Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

The observed in vitro and in vivo benefit of combination treatment with anti-human immunodeficiency virus (HIV) agents prompted us to examine the potential of resistance development when two protease inhibitors are used concurrently. Recombinant HIV-1 (NL4-3) proteases containing combined resistance...

Full description

Saved in:
Bibliographic Details
Main Authors: Rose, R E, Gong, Y F, Greytok, J A, Bechtold, C M, Terry, B J, Robinson, B S, Alam, M, Colonno, R J, Lin, P F
Format: Artigo
Language:Inglês
Published: 1996
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC39996/
https://ncbi.nlm.nih.gov/pubmed/8643685
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items